Explore All Access
Check if your research matches the topics covered in Drugs?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Drugs : Impact Factor & More
eISSN: 1179-1950pISSN: 0012-6667
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Drugs Key Metrics
CiteScore 
16.3
H-Index
179
Impact Factor
10 - 15
SJR
Q1Pharmacology (medical)
SNIP
2.68
Topics Covered on Drugs
Lung cancer
Multiple sclerosis
Body mass index
Breast cancer
Hemodialysis
Antipruritic Activity
Psoriatic arthritis
Spinal muscular atrophy
Type 2 diabetes
Lonafarnib
Gefitinib
Psoriasis
Immunotherapy
Migraine
Filgotinib
Clinical trial
Dexamethasone
Overall survival
Capsaicin
Fabry disease
Drugs Journal Specifications
| Overview | |
| Publisher | ADIS INT LTD |
| Language | English |
| Frequency | Semi-monthly |
| General Details | |
| Language | English |
| Frequency | Semi-monthly |
| Publication Start Year | 1971 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Drugs ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Drugs
Advanced-Stage Chronic Myeloid Leukemia: Options for Difficult Treatment Situations.
- 6 Dec 2024
- Drugs
Correction: Vorasidenib: First Approval.
- 2 Dec 2024
- Drugs
Acknowledgement to Referees.
- 28 Nov 2024
- Drugs
Treatment Approaches for Carbapenem-Resistant Acinetobacter baumannii Infections.
- 28 Nov 2024
- Drugs
Fulzerasib: First Approval.
- 26 Nov 2024
- Drugs
Seladelpar: First Approval.
- 22 Nov 2024
- Drugs
Advanced-Stage Chronic Myeloid Leukemia: Options for Difficult Treatment Situations.
- 6 Dec 2024
- Drugs
Correction: Vorasidenib: First Approval.
- 2 Dec 2024
- Drugs
Acknowledgement to Referees.
- 28 Nov 2024
- Drugs
Treatment Approaches for Carbapenem-Resistant Acinetobacter baumannii Infections.
- 28 Nov 2024
- Drugs
Fulzerasib: First Approval.
- 26 Nov 2024
- Drugs
Seladelpar: First Approval.
- 22 Nov 2024
- Drugs
Compare Similar Journals with Drugs
Select Journals to Compare with Drugs
Total journals - 9
You can select up to 3 Journals at a time
Medicine
Publisher: Elsevier
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
Scientific Reports
Publisher: NATURE PORTFOLIO
Journal of Clinical Medicine
Publisher: MDPI
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
BMJ Open
Publisher: BMJ PUBLISHING GROUP
International Journal of Molecular Sciences
Publisher: MDPI
Annals of Oncology
Publisher: ELSEVIER
Frontiers in Pharmacology
Publisher: FRONTIERS MEDIA SA
0 Journals Selected to compare with
Drugs
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Drugs
How long has Drugs been actively publishing? 
Drugs has been in operation since 1971 till date.
What is the publishing frequency of Drugs?
Drugs published with a Semi-monthly frequency.
How many articles did Drugs publish last year?
In 2023, Drugs publsihed 161 articles.
What is the eISSN & pISSN for Drugs?
For Drugs, eISSN is 1179-1950 and pISSN is 0012-6667.
What is Citescore for Drugs?
Citescore for Drugs is 16.3.
What is the H Index for Drugs ?
H Index for Drugs is 179.
What is SNIP score for Drugs?
SNIP score for Drugs is 2.68.
What is the SJR for Drugs?
SJR for Drugs is Q1.
Who is the publisher of Drugs?
ADIS INT LTD is the publisher of Drugs.
